Spectrum Wealth Counsel’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Spectrum Wealth Counsel’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-300	Closed	-$27K	–	401
2024 Q4	$27K	Sell	300 -34	-10%	-$3.29K	﹤0.01%	192
2024 Q3	$33K	Sell	334 -6	-2%	-$590	﹤0.01%	200
2024 Q2	$31.5K	Hold	340	–	–	﹤0.01%	233
2024 Q1	$32.3K	Buy	340 +300	+750%	+$27.8K	﹤0.01%	231
2023 Q4	$3.57K	Buy	+40	New	+$2.97K	﹤0.01%	299

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Spectrum Wealth Counsel's XBI Position: Q1 2025 in Review

Spectrum Wealth Counsel sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 300 shares — an estimated $27K sold.

Spectrum Wealth Counsel first reported a position in XBI in Q4 2023 and held it in 5 quarters. The position peaked at $33K in Q3 2024. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Spectrum Wealth Counsel reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Spectrum Wealth Counsel sold 300 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $27K.
Spectrum Wealth Counsel first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 5 quarters.
Spectrum Wealth Counsel's State Street SPDR S&P Biotech ETF position peaked at $33K in Q3 2024.
682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Spectrum Wealth Counsel's 13F filing for Q1 2025, filed 7 May 2025.